Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 204

Results For "WHO"

2860 News Found

Sanofi teams up with McLaren Racing to accelerate industrial excellence
News | April 27, 2022

Sanofi teams up with McLaren Racing to accelerate industrial excellence

Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance


Enhertu granted Breakthrough Therapy Designation in the US for patients with HER2-low metastatic breast cancer
Biotech | April 27, 2022

Enhertu granted Breakthrough Therapy Designation in the US for patients with HER2-low metastatic breast cancer

Enhertu has now been granted five Breakthrough Therapy Designations, including three in breast cancer and one in both lung and gastric cancers


SPARSH Hospital introduces high precision Surgical Imaging and Navigation system
Hospitals | April 27, 2022

SPARSH Hospital introduces high precision Surgical Imaging and Navigation system

The StealthStation S8 and O-arm Surgical Navigation solution make a complex surgery seem more routine and free of any errors


USFDA approves first Covid-19 treatment for young children
Drug Approval | April 26, 2022

USFDA approves first Covid-19 treatment for young children

This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age


Biocytogen signs RenMab/RenLite licensing agreement with BeiGene
Biotech | April 26, 2022

Biocytogen signs RenMab/RenLite licensing agreement with BeiGene

In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)


Roche and Fitterfly co-create 90-day diabetes programme
Startup | April 26, 2022

Roche and Fitterfly co-create 90-day diabetes programme

Designed to give instant insights on blood sugar, in-depth nutrition and wellness, this programme provides fitness assessments, personalisation and reports for doctors


Sygnature Discovery acquires Peak Proteins
Biotech | April 26, 2022

Sygnature Discovery acquires Peak Proteins

Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes


Glenmark is the first to launch Teneligliptin and Pioglitazone Fixed-Dose Combination
News | April 25, 2022

Glenmark is the first to launch Teneligliptin and Pioglitazone Fixed-Dose Combination

The innovative Fixed-Dose Combination will help improving the glycemic control among adult patients with insulin resistance, those whose diabetes is uncontrolled by metformin; and also those who require addition of Teneliglitptin and Pioglitazone as separate drugs.


Global AYUSH meet ends with promise of Rs 9000 cr. in investment
News | April 25, 2022

Global AYUSH meet ends with promise of Rs 9000 cr. in investment

Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal


Aleor Dermaceuticals receives USFDA approval for Clobestasol
Drug Approval | April 25, 2022

Aleor Dermaceuticals receives USFDA approval for Clobestasol

Clobetasol Propionate Foam, 0.05% has an estimated market size of US $ IO million for twelve months ending Dec 2021 according to IQVIA